Chang Hyun Jeon

Title: Chang Hyun Jeon: Innovator in Pharmaceutical Composition

Introduction

Chang Hyun Jeon is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating serious medical conditions. With a total of 2 patents to his name, his work focuses on innovative solutions for complex health issues.

Latest Patents

Chang Hyun Jeon's latest patents include a pharmaceutical composition for preventing or treating graft versus host disease (GVHD) that comprises thiamine derivatives. This invention utilizes fursultiamine as the active ingredient, which has been shown to alleviate weight loss in patients suffering from GVHD, reduce inflammatory cell infiltration in the liver and colon, and effectively inhibit the production of allogeneic CD4+ IFNγ+ T cells. His other patent is a pharmaceutical composition containing a thiamine derivative for the prevention or treatment of sepsis. This composition aims to prevent, alleviate, or treat sepsis by using fursultiamine or allithiamine to inhibit the expressions of CD40, CD86, and TNFα.

Career Highlights

Chang Hyun Jeon is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science through innovative pharmaceutical solutions.

Collaborations

He collaborates with esteemed colleagues, including Eun Jung Choi and Tae-Hwan Kwon, who contribute to his research endeavors and help enhance the impact of his inventions.

Conclusion

Chang Hyun Jeon stands out as a dedicated inventor in the pharmaceutical field, with a focus on developing compositions that address critical health challenges. His contributions are paving the way for advancements in treatment options for conditions like GVHD and sepsis.